Revolutionizing Nanovaccines: A New Era of Immunization
Infectious diseases continue to pose a significant global health threat. To combat these challenges, innovative vaccine technologies are urgently needed. Nanoparticles (NPs) have unique properties and have emerged as a promising platform for developing next-generation vaccines. Nanoparticles are rev...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/2/126 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849720134920306688 |
|---|---|
| author | Mohammed Saleh Ahmed El-Moghazy Adel H. Elgohary WesamEldin I. A. Saber Yosra A. Helmy |
| author_facet | Mohammed Saleh Ahmed El-Moghazy Adel H. Elgohary WesamEldin I. A. Saber Yosra A. Helmy |
| author_sort | Mohammed Saleh |
| collection | DOAJ |
| description | Infectious diseases continue to pose a significant global health threat. To combat these challenges, innovative vaccine technologies are urgently needed. Nanoparticles (NPs) have unique properties and have emerged as a promising platform for developing next-generation vaccines. Nanoparticles are revolutionizing the field of vaccine development, offering a new era of immunization. They allow the creation of more effective, stable, and easily deliverable vaccines. Various types of NPs, including lipid, polymeric, metal, and virus-like particles, can be employed to encapsulate and deliver vaccine components, such as mRNA or protein antigens. These NPs protect antigens from degradation, target them to specific immune cells, and enhance antigen presentation, leading to robust and durable immune responses. Additionally, NPs can simultaneously deliver multiple vaccine components, including antigens, and adjuvants, in a single formulation, simplifying vaccine production and administration. Nanovaccines offer a promising approach to combat food- and water-borne bacterial diseases, surpassing traditional formulations. Further research is needed to address the global burden of these infections. This review highlights the potential of NPs to revolutionize vaccine platforms. We explore their mechanisms of action, current applications, and emerging trends. The review discusses the limitations of nanovaccines, innovative solutions and the potential role of artificial intelligence in developing more effective and accessible nanovaccines to combat infectious diseases. |
| format | Article |
| id | doaj-art-1ec51b137e9943efa8f3f333770ff54c |
| institution | DOAJ |
| issn | 2076-393X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj-art-1ec51b137e9943efa8f3f333770ff54c2025-08-20T03:12:01ZengMDPI AGVaccines2076-393X2025-01-0113212610.3390/vaccines13020126Revolutionizing Nanovaccines: A New Era of ImmunizationMohammed Saleh0Ahmed El-Moghazy1Adel H. Elgohary2WesamEldin I. A. Saber3Yosra A. Helmy4Department of Veterinary Science, Martin-Gatton College of Agriculture, Food, and Environment, University of Kentucky, Lexington, KY 40546, USADepartment of Microbiology and Plant Pathology, University of California, Riverside, CA 92521, USADepartment of Hygiene and Zoonoses, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, EgyptMicrobial Activity Unit, Department of Microbiology, Soils, Water and Environment Research Institute, Agricultural Research Center, Giza 12619, EgyptDepartment of Veterinary Science, Martin-Gatton College of Agriculture, Food, and Environment, University of Kentucky, Lexington, KY 40546, USAInfectious diseases continue to pose a significant global health threat. To combat these challenges, innovative vaccine technologies are urgently needed. Nanoparticles (NPs) have unique properties and have emerged as a promising platform for developing next-generation vaccines. Nanoparticles are revolutionizing the field of vaccine development, offering a new era of immunization. They allow the creation of more effective, stable, and easily deliverable vaccines. Various types of NPs, including lipid, polymeric, metal, and virus-like particles, can be employed to encapsulate and deliver vaccine components, such as mRNA or protein antigens. These NPs protect antigens from degradation, target them to specific immune cells, and enhance antigen presentation, leading to robust and durable immune responses. Additionally, NPs can simultaneously deliver multiple vaccine components, including antigens, and adjuvants, in a single formulation, simplifying vaccine production and administration. Nanovaccines offer a promising approach to combat food- and water-borne bacterial diseases, surpassing traditional formulations. Further research is needed to address the global burden of these infections. This review highlights the potential of NPs to revolutionize vaccine platforms. We explore their mechanisms of action, current applications, and emerging trends. The review discusses the limitations of nanovaccines, innovative solutions and the potential role of artificial intelligence in developing more effective and accessible nanovaccines to combat infectious diseases.https://www.mdpi.com/2076-393X/13/2/126nanoparticles (NPs)nanoparticle-based vaccinespreclinical and clinical trialsregulatory challengesfuture innovationsfood safety |
| spellingShingle | Mohammed Saleh Ahmed El-Moghazy Adel H. Elgohary WesamEldin I. A. Saber Yosra A. Helmy Revolutionizing Nanovaccines: A New Era of Immunization Vaccines nanoparticles (NPs) nanoparticle-based vaccines preclinical and clinical trials regulatory challenges future innovations food safety |
| title | Revolutionizing Nanovaccines: A New Era of Immunization |
| title_full | Revolutionizing Nanovaccines: A New Era of Immunization |
| title_fullStr | Revolutionizing Nanovaccines: A New Era of Immunization |
| title_full_unstemmed | Revolutionizing Nanovaccines: A New Era of Immunization |
| title_short | Revolutionizing Nanovaccines: A New Era of Immunization |
| title_sort | revolutionizing nanovaccines a new era of immunization |
| topic | nanoparticles (NPs) nanoparticle-based vaccines preclinical and clinical trials regulatory challenges future innovations food safety |
| url | https://www.mdpi.com/2076-393X/13/2/126 |
| work_keys_str_mv | AT mohammedsaleh revolutionizingnanovaccinesaneweraofimmunization AT ahmedelmoghazy revolutionizingnanovaccinesaneweraofimmunization AT adelhelgohary revolutionizingnanovaccinesaneweraofimmunization AT wesameldiniasaber revolutionizingnanovaccinesaneweraofimmunization AT yosraahelmy revolutionizingnanovaccinesaneweraofimmunization |